Literature DB >> 3298302

The functional status of ESRD patients as measured by the Sickness Impact Profile.

L G Hart, R W Evans.   

Abstract

This study describes and compares the perceived sickness-related behavioral dysfunction of 859 end-stage renal disease (ESRD) patients from 11 centers according to treatment modality via the Sickness Impact Profile (SIP). The unadjusted functional status of ESRD patients differed significantly by treatment modality. Transplantation patients were least functionally limited followed in order by home dialysis, continuous peritoneal dialysis, and in-center dialysis patients. The largest overall differences were for the sleep and rest, work, recreation and pastimes, and home management SIP categories. Regression analysis revealed that many of the large observed intermodality differences in functional status may have resulted from casemix variations (e.g. age and comorbidity differences). Only SIP score differences between transplantation and other treatment modality patients remained significant following the introduction of casemix controls. Results do not justify choosing one dialysis modality over another because of differences in perceived dysfunction.

Entities:  

Mesh:

Year:  1987        PMID: 3298302     DOI: 10.1016/s0021-9681(87)80041-3

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  22 in total

1.  [Changes in the quality of life after organ transplantations].

Authors:  M Niechzial; T Grobe; H Dörning; H Raspe; E Nagel
Journal:  Soz Praventivmed       Date:  1999

2.  Assessment of quality of life in a single centre dialysis population using the KDQOL-SF questionnaire.

Authors:  P Carmichael; J Popoola; I John; P E Stevens; A R Carmichael
Journal:  Qual Life Res       Date:  2000-03       Impact factor: 4.147

3.  The SF36 as an outcome measure of services for end stage renal failure.

Authors:  J P Wight; L Edwards; J Brazier; S Walters; J N Payne; C B Brown
Journal:  Qual Health Care       Date:  1998-12

Review 4.  Measuring health status? A review of the sickness impact and functional limitations profiles.

Authors:  S J Williams
Journal:  Health Care Anal       Date:  1996-11

5.  Quality of life in type 1 (insulin-dependent) diabetic patients prior to and after pancreas and kidney transplantation in relation to organ function.

Authors:  W Piehlmeier; M Bullinger; J Nusser; A König; W D Illner; D Abendroth; W Land; R Landgraf
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

Review 6.  The potential of biotechnology to improve the quality of life of patients with renal failure.

Authors:  W E Bloembergen; A Laupacis
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

7.  The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions.

Authors:  A Gardulf; H Björvell; R Gustafson; L Hammarström; C I Smith
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

Review 8.  A review of quality of life in chronic renal failure.

Authors:  D S Parsons; D C Harris
Journal:  Pharmacoeconomics       Date:  1997-08       Impact factor: 4.981

9.  Reflections on supply-demand mismatch in dialysis services in Ontario.

Authors:  N K Choudhry; C D Naylor
Journal:  CMAJ       Date:  1995-09-01       Impact factor: 8.262

10.  Individual-patient monitoring in clinical practice: are available health status surveys adequate?

Authors:  C A McHorney; A R Tarlov
Journal:  Qual Life Res       Date:  1995-08       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.